Bleeding in orthopaedic surgery: The role of blood transfusion and erythropoietin alpha

Acta Biomedica

Volumn 81, Issue 2, 2010, Pages 125-129

  Soviero, Felicia ^a   Geraci, Alessandro ^b   Termine, Stefania ^b   Sanfilippo, Antonio ^b   Maritano, Roberta Margherita ^c   D'Arienzo, Michele ^b   Maiorana, A M ^b   Damiani, Provvidenza ^b   Tomasello, Giovanni ^b  

^a Orthopedic Traumatological Center   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Bleeding; Erythropoietin; High energy trauma

Indexed keywords

ERYTHROPOIETIN ALPHA; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; ANTIANEMIC AGENT; EPO PROTEIN, HUMAN; ERYTHROPOIETIN;

ARTICLE; BLEEDING; BLOOD TRANSFUSION; COMMINUTED FRACTURE; DRUG EFFICACY; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPOVOLEMIA; HYPOVOLEMIC SHOCK; INJURY; MORBIDITY; OPERATION DURATION; ORTHOPEDIC SURGERY; OSTEOPOROSIS; OSTEOSYNTHESIS; OXYGEN TENSION; PELVIS FRACTURE; STROKE; ORTHOPEDICS; REVIEW; SHOCK;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; ERYTHROPOIETIN; HEMATINICS; HUMANS; ORTHOPEDICS; SHOCK; WOUNDS AND INJURIES;

EID: 79952274357     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Cummings SR, Rubin SM, Black D. The future of hip fractures in the United States. Numbers, costs, and potential effects of postmenopausal estrogen. Clin Orthop 1990; 252: 163-6.
2. Jaicks RR, Cohn SM, Moller BA. Early fracture fixation may be deleterious after head injury. J Trauma 1997; 42: 1-5.
3. Goodnough LT, Riddell J 4th, Verbrugge D, Marcus RE. Blood transfusions in hip fracture patients: implications for blood conservation programs. J Orthop Trauma 1993; 7: 47-51.
4. Committee on Trauma ACOS. Advanced Trauma Life Support Course for Physicians 1993 Student Manual. Chicago, IL: Uniform Copyright Protection, 1993.
5. Tscherne H, Regel G. Care of the polytraumatised patient. J Bone Joint Surg Br 1996; 78: 840-52.
6. Lonner JH, Koval KJ. Polytrauma in the elderly. Clin Or thop 1995; 318: 136-43.
7. Tscherne H, Regel G, Pape HC, Pohlemann T, Krettek C. Internal fixation of multiple fractures in patients with polytrauma. Clin Orthop 1998; 347: 62-78.
8. Seekamp A, Regel G, Tscherne H. Rehabilitation and rein tegration of multiply injured patients: an outcome study with special reference to multiple lower limb fractures. Injury 1996; 27: 133-8.
9. Egol KA, Koval KJ, Zuckerman JD. Functional recovery following hip fracture in the elderly. J Orthop Trauma 1997; 11: 594-599.
10. Agolini SF, Shah K, Jaffe J, Newcomb J, Rhodes M, Reed JF 3rd. Arterial embolization is a rapid and effective technique for controlling pelvic fracture hemorrhage. J Trauma 1997; 43: 395-9.
11. Lemos MJ, Healy WL. Blood transfusion in orthopaedic operations. J Bone Joint Surg Am 1996; 78: 1260-70.
12. Kanter MH, van Maanen D, Anders KH, Castro F, Mya WW, Clark K. Preoperative autologous blood donations before elective hysterectomy. JAMA 1996; 276: 798-801.
13. Sire JM, Michelet C, Mesnard R, et al. Septic shock due to Yersinia enterocolitica after autologous transfusion. Clin Infect Dis 1993; 17: 954-5.
14. Blumberg N, Heal JM. Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am J Med 1996; 01: 299-308.
15. Faris PM, Ritter MA, Abels RI. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J Bone Joint Surg Am 1996; 78: 62-72.
16. Ness PM, Bourke DL, Walsh PC. A randomized trial of perioperative hemodilution versus transfusion of preoperatively deposited autologous blood in elective surgery. Transfusion 1992; 32: 226-30.
17. Lemos MJ, Healy WL. Blood transfusion in orthopaedic operations. J Bone Joint Surg Am 1996; 78: 1260-70.
18. Glaspy J. The impact of Epoetin alfa on quality of life during cancer chemotherapy: a fresh look at an old problem. Semin Hematol 1997; 34 (suppl 2, pt 3): 20-6.
19. Goodnough LT, Merkel K. Parenteral iron and recombi nant human erythropoietin therapy to stimulate erythropoiesis in patients undergoing repair of hip fracture. Hematology 1996; 1: 163-6.
20. Canadian Orthopedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993; 341: 1227-32.
21. Stowell CP, Chandler H, Jove M, Guilfoyle M, Wacholtz MC. An open-label,randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty. Orthopedics 1999; 22 (1 Suppl): S105-12.
22. de Andrade JR, Frei D, Guilfoyle M. Integrated analysis of thrombotic/vascular event occurrence in epoetin alfatreated patients undergoing major, elective orthopedic surgery.
23. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anaemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anaemia. Blood 2004; 104: 2263-8.
24. Stolzfus RJ, Dreyfuss ML. Guidelines for the Use of Iron Supplementation to Prevent and Treat Iron Deficiency Anaemia. Genève: WorldHealth Organization, 1998.
25. Carson JL, Altman DG, Duff A, et al. Risk of bacterial infection associated with allogenic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999; 39: 694-700.
26. Cuenca J, Martínez AA, Panisello JJ, Herrera A, Sola A. Estudio de la evolución de la hemoglobina y el hematocrito según el tipo de fractura de cadera. Rev Ortop Traumatol 2002; 1: 54-7.
27. Zauber NP, Zauber AG, Gordon FJ, et al. Iron supplemen tation after femoral head replacement for patients with normal iron stores. JAMA 1992; 267: 525-7.
28. Sutton PM, Cresswell T, Livesey JP, Speed K, Bagga T. Treatment of anaemia after joint replacement. A double-blind, randomised, controlled trial of ferrous sulphate versus placebo. J Bone Joint Surg Br 2004; 86: 31-3.
29. Tamir L, Fradin Z, Fridlander M, et al. Recombinant human erythropoietin reduces allogeneic blood transfusion requirements in patients undergoing major orthopedic surgery. Haematologia 2000; 30: 193-201.
30. Goodnough LT, Shander A, Spivak JL, et al. Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg 2005; 101: 1858-61.
31. Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and outcomes of anemia in surgery: A systematic review of the literature. Am J Med 2004; 116 (suppl 7A): 58S-69S.
32. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81: 2-10.
33. Myers E, Grady PO, Dolan AM. The influence of preclin ical anaemia on outcome following total hip replacement. Arch Orthop Trauma Surg 2004; 124: 699-701
34. Dunne JR, Malone D, Tracy JK, Gannon C, Napolitano LM. Perioperative anemia: An independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 2002; 102: 237-44.
35. Gruson KI, Aharonoff GB, Egol KA, Zuckerman JD, Koval KJ. The relationship between admission hemoglobin level and outcome after hip fracture. J Orthop Trauma 2002; 16: 39-44.